BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8171642)

  • 1. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):749. PubMed ID: 8171642
    [No Abstract]   [Full Text] [Related]  

  • 2. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
    Beilke J; Johnson Z; Kuhl N; Gill RG
    Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine specificity of class I MHC recognition in islet allografts.
    Ferguson D; Kohli N; Munn SR
    Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924
    [No Abstract]   [Full Text] [Related]  

  • 4. Class I major histocompatibility complex antigen disparity is not a barrier to successful pancreatic islet cell engraftment.
    Jain K; Cai BR; Patel S; Anderson M; Miller D; Smith BH; Rubin AL; Suthanthiran M
    Transplant Proc; 1994 Dec; 26(6):3323-4. PubMed ID: 7998155
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunomodulation and fish-to-mouse islet xenograft survival.
    Wright JR; Kearns H
    Transplant Proc; 1994 Dec; 26(6):3489. PubMed ID: 7998240
    [No Abstract]   [Full Text] [Related]  

  • 6. beta-2 Microglobulin gene disruption prolongs murine islet allograft survival in NOD mice.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):752. PubMed ID: 8171644
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of concanavalin A on mouse islet cell transplantation.
    Zhu XY; He J; Yang PA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):954-6. PubMed ID: 3152647
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permanent acceptance of mitomycin C-treated islet allograft.
    Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
    Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal transplantation of microencapsulated canine islet allografts with short-term, low-dose cyclosporine for treatment of pancreatectomy-induced diabetes in dogs.
    Wahoff DC; Stephanian E; Gores PF; Soon-Shiong P; Hower C; Lloveras JK; Sutherland DE
    Transplant Proc; 1994 Apr; 26(2):804. PubMed ID: 8171668
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
    Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
    Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of CD4+ and CD8+ T cells in proislet allograft and xenograft rejection.
    Simeonovic CJ; Wilson JD
    Transplant Proc; 1992 Feb; 24(1):252-3. PubMed ID: 1539270
    [No Abstract]   [Full Text] [Related]  

  • 13. Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice.
    Iwata H; Takagi T; Yamashita K; Kobayashi K; Amemiya H
    Transplant Proc; 1992 Jun; 24(3):934. PubMed ID: 1604671
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment.
    Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Kita Y; Kanai T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):975. PubMed ID: 7680173
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantation.
    Katz SM; Browne B; Phan T; Wang ME; Bennett CF; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Dec; 27(6):3214. PubMed ID: 8539920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent long-term allograft survival in murine pancreatic islet transplants without immunosuppression.
    Jain K; Cai BR; Patel S; Yang H; Smith BH; Suthanthiran M; Rubin AL
    Transplant Proc; 1994 Dec; 26(6):3492-3. PubMed ID: 7998243
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of rapamycin on islet xenograft survival.
    Lu X; Schuurman HJ; Borel JF
    Transplant Proc; 1994 Jun; 26(3):1128-9. PubMed ID: 8029857
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cryopreservation on islet recovery and in vivo function.
    Cattral MS; Lakey JR; Warnock GL; Kneteman NM; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3336. PubMed ID: 8539978
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term survival of Wistar-Furth islet allografts in Lewis rats is associated with spontaneously tolerated orthotopic liver allografts.
    Wan X; Yu W; Yang H; al-Abdullah I; Coddington D; Bitter-Suermann H; Wright JR
    Transplant Proc; 1994 Apr; 26(2):723-4. PubMed ID: 8171625
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.